Likelihood Models of Somatic Mutation and Codon Substitution in Cancer Genes

Genetics

Volumn 165, Issue 2, 2003, Pages 695-705

  Yang, Ziheng ^b   Ro, Simon ^a   Rannala, Bruce ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PYRIMIDINE DERIVATIVE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GENETICS; CELL LINEAGE; CODON; CPG ISLAND; DATA BASE; DNA BINDING; HUMAN; MISSENSE MUTATION; MUTATION RATE; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SOMATIC MUTATION; STATISTICAL MODEL; STOP CODON; TRANSACTIVATION;

DATA INTERPRETATION, STATISTICAL; LIKELIHOOD FUNCTIONS; MODELS, GENETIC; MUTATION; NEOPLASMS; ONCOGENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0242318328     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ARAIKE, H., 1973 Information theory and an extension of maximum likelihood principle, pp. 267-281 in 2nd International Symposium on Information Theory. Akademia Kiado, Budapest.
2. AKASHI, H., 1994 Synonymous codon usage in Drosophila melanogaster: natural selection and translational accuracy. Genetics 136: 927-935.
3. BALINT, E., and K. H. VOUSDEN, 2001 Activation and activities of the p53 tumor suppressor protein. Br. J. Cancer 85: 1813-1823.
4. BENNETT, W. P., S. P. HUSSAIN, K. H. VAHAKANGAS, M. A. KHAN and P. G. SHIELDS, 1999 Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J. Pathol. 187: 8-18.
5. BISHOP, J. M., 1991 Molecular themes in oncogenesis. Cell 64: 235-248.
6. BRASH, D. E., J. A. RUDOLPH, J. A. SIMON, A. LIN, G. J. MCKENNA et al., 1991 A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88: 10124-10128.
7. CHÉNE, P., 2001 The role of tetramerization in p53 function. Oncogene 20: 2611-2617.
8. COOPER, D. N., and H. YOUSSOUFIAN, 1988 The CpG dinucleotide and human genetic disease. Hum. Genet. 87: 151-155.
9. DELEO, A. B., G. JAY, E. APPELLA, G. C. DUBOIS, L. W. LAW et al., 1979 Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc. Natl. Acad. Sci. USA 76: 2420-2424.
10. HANAHAN, D., and R.A. WEINBERC, 2000 The hallmarks of cancer. Cell 100: 57-70.
11. HOLLSTEIN, M., M. K. RICE, M. S. GREENBLATT, T. SOUSSI, R. FUCHS et al., 1994 Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22: 3551-3555.
12. HUSSAIN, S. P., and C. C. HARRIS, 1999 p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat. Res. 428: 23-32.
13. JEFFREY, P. D., S. GORINA and N. P. PAVLETICH, 1995 Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267: 1498-1502.
14. JIANG, M., T. AXE, R. HOLGATE, C. P. RUBBI, A. L. OKOROKOV et al., 2001 p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress. Oncogene 20: 5449-5458.
15. LAIRD, P. W., and R. JAENISCH, 1996 The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet. 30: 441-464.
16. LANE, D. P., and L. V. CRAWFORD, 1979 T antigen is bound to a host protein in sv40-transformed cells. Nature 278: 261-263.
17. LEVINE, A. J., 1997 p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
18. LEVINE, A. J., M. C. WU, A. CHANG, A. SILVER, E. A. ATTIYEH et al., 1995 The spectrum of mutations at the p53 locus. Ann. NY Acad. Sci. 768: 111-128.
19. LIN, J., J. CHEN, B. ELENBAAS and A. J. LEVINE, 1994 Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8: 1235-1246.
20. LINZER, D. I., and A. J. LEVINE, 1979 Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43-52.
21. MAY, P., and E. MAY, 1999 Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621-7636.
22. OZOREN, N., and W. S. EL-DEIRY, 2000 Introduction to cancer genes and growth control, pp. 3-43 in DNA Alterations in Cancer: Genetics and Epigenetic Changes, edited by M. EHRLICH. Eaton Pressing, Natick, MA.
23. PIETENPOL, J. A., T. TOKINO, S. THIAGALINGAM, W. S. EL-DEIRY, K. W. KINZLER et al., 1994 Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91: 1998-2002.
24. PONDER, B. A., 2001 Cancer genetics. Nature 411: 336-341.
25. RODIN, S. N., and A. S. RODIN, 2000 Human lung cancer and p53: the interplay between mutagenesis and selection. Proc. Natl. Acad. Sci. USA 97: 12244-12249.
26. ROEMER, K., 1999 Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators. Biol. Chem. 380: 879-887.
27. SLATKIN, M., and B. RANNALA, 1997 The sampling distribution of disease-associated alleles. Genetics 147: 1855-1861.
28. SOUSSI, T., and C. BEROUD, 2001 Assessing TP53 status in human tumours to evaluate clinical outcome. Nat. Rev. Cancer 1: 233-240.
29. SOUSSI, T., C. CARON DE FROMENTEL and P. MAY, 1990 Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5: 945-952.
30. TAYLOR, H. M., and S. KARLIN, 1984 An Introduction to Stochastic Modeling. Academic Press, New York.
31. VENKITARAMAN, A. R., 2002 Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182.
32. VOGELSTEIN, B., E. R. FEARON, S. R. HAMILTON, S. E. KERN, A. C. PREISINGER et al., 1988 Genetic alterations during colorectal tumor development. N. Engl. J. Med. 319: 525-532.
33. WALKER, D. R., J. P. BOND, R. E. TARONE, C. C. HARRIS, W. MAKALOWSKI, et al., 1999 Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene 18: 211-218.
34. WATERMAN, J. L., J. L. SHENK and T. D. HALAZONETIS, 1995 The dihedral symmetry, of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J. 14:512-519.
35. WEINBERG, R. A., 1995 The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
36. YANG, Z., 2001 Adaptive molecular evolution, pp. 327-348 in Handbook of Statistical Genetics, edited by D. J. BALDING, C. CANNINGS and M. BISHOP. John Wiley & Sons, New York.